Background Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis in
foetal life. Researchers have recently attempted to use anti‐VEGF agents for the treatment of …

The population of infants at risk for retinopathy of prematurity (ROP) varies by world region;
in countries with well developed neonatal intensive care services, the highest risk infants are …

Background Despite increasing worldwide use of anti-vascular endothelial growth factor
agents for treatment of retinopathy of prematurity (ROP), there are few data on their ocular …

Retinopathy of prematurity (ROP) is a major complication of preterm birth. It encompasses a
spectrum of pathologies that affect vision, from mild disease that resolves spontaneously to …

Retinopathy of prematurity (ROP) is an important cause of childhood blindness globally, and
the incidence is rising. The disease is characterized by initial arrested retinal vascularization …

Importance Intravitreous injections of bevacizumab (IVB) have been found to be effective for
the treatment of retinopathy of prematurity (ROP). However, serum levels of vascular …

Retinal endothelial cells line the arborizing microvasculature that supplies and drains the
neural retina. The anatomical and physiological characteristics of these endothelial cells are …

Current Opinion in Pediatrics Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …

During development, the retinal vasculature grows toward hypoxic areas in an organized
fashion. By contrast, in ischemic retinopathies, new blood vessels grow out of the retinal …

Purpose The current study aims to investigate the neurodevelopment of premature infants
after intravitreal injections of bevacizumab (IVB) for the treatment of retinopathy of …